GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Price-to-Free-Cash-Flow

LTR Pharma (ASX:LTP) Price-to-Free-Cash-Flow : (As of Jun. 07, 2024)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Price-to-Free-Cash-Flow?

As of today (2024-06-07), LTR Pharma's share price is A$0.64. LTR Pharma does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for LTR Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:LTP's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.425
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

LTR Pharma's Free Cash Flow per Share for the six months ended in Jun. 2023 was A$-0.01.

LTR Pharma Price-to-Free-Cash-Flow Historical Data

The historical data trend for LTR Pharma's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Price-to-Free-Cash-Flow Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow - - -

Competitive Comparison of LTR Pharma's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, LTR Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Price-to-Free-Cash-Flow falls into.


LTR Pharma Price-to-Free-Cash-Flow Calculation

LTR Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.64/
=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

LTR Pharma  (ASX:LTP) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

LTR Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Price-to-Free-Cash-Flow
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines